Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent.

Chen, Jia-Hong; Wu, Alexander T H; Lawal, Bashir; Tzeng, David T W; Lee, Jih-Chin; Ho, Ching-Liang; Chao, Tsu-Yi

Chen, Jia-Hong; Wu, Alexander T H; Lawal, Bashir; Tzeng, David T W; Lee, Jih-Chin; Ho, Ching-Liang; Chao, Tsu-Yi.

Afiliação

Chen JH; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Wu ATH; Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, National Defence Medical Center, Taipei City 114, Taiwan.
Lawal B; The PhD Program of Translational Medicine, College of Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Tzeng DTW; Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Lee JC; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan.
Ho CL; Taipei Heart Institute (THI), Taipei Medical University, Taipei 11031, Taiwan.
Chao TY; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.

Cancers (Basel) ; 13(15)2021 Jul 30.

Article em En | MEDLINE | ID: mdl-34359748